Placebo 230    230      230       230         229       227       224      222        216       213       2092†-1.5-1.0-0.50.00.51.0 Time (weeks)LSM (SE) change in body weight (kg)(F) n at week Exenatide QW 231           225             222            214             211           208            207            206 Placebo 230           228             226            220             216           210            208            209**** * 0 1 2 4 8 12 16 20 24 287.58.08.59.09.5 Time (weeks)Mean (SE) HbA1c (%)(A) Exenatide QW + IG (n = 231) Placebo + IG (n = 230) S- 8 - 4 0 8 4 1 21 62 02 42 8 n at week Exenatide QW 230   229      230      231        226       223        214       212        208       208       206 Placebo  229   229      228      230        227       226        217       215        209       208       207* * * * *** † FIGURE 2 A, Mean HbA1c from screening to week 28. B, Proportion of patients achieving HbA1c <7.0% (<53 mmol/mol) and HbA1c <7.0%